A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplification
Authors
Van Cutsem, EBang, Y
Mansoor, Was
Petty, R
Chao, Y
Cunningham, D
Ferry, D
Smith, N
Frewer, P
Ratnayake, J
Stockman, P
Kilgour, E
Landers, D
Affiliation
Unit of Digestive Oncology, University Hospitals Leuven and KU Leuven, Leuven, BelgiumIssue Date
2017-06
Metadata
Show full item recordCitation
A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplification 2017, 28 (6):1316 Annals of OncologyJournal
Annals of OncologyDOI
10.1093/annonc/mdx107Type
Meetings and ProceedingsLanguage
enISSN
0923-75341569-8041
ae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdx107